{"nct_id":"NCT05070546","title":"A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2021-09-29","start_date_type":"ACTUAL","primary_completion_date":"2022-08-12","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}